Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Aug 3;3(3):e00063.
doi: 10.1042/AN20110014.

Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model

Affiliations
Review

Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model

Valerie L Jacobs et al. ASN Neuro. .

Abstract

GBM (glioblastoma multiforme) is a highly aggressive brain tumour with very poor prognosis despite multi-modalities of treatment. Furthermore, recent failure of targeted therapy for these tumours highlights the need of appropriate rodent models for preclinical studies. In this review, we highlight the most commonly used rodent models (U251, U86, GL261, C6, 9L and CNS-1) with a focus on the pathological and genetic similarities to the human disease. We end with a comprehensive review of the CNS-1 rodent model.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Characteristics of the CNS-1 rat glioma model
(a) MRI of the original tumour in which the CNS-1 tumour cell line was derived. (b) T1-weighted MRI of 1×105 CNS-1 cells in Lewis rat on day 15. Tumour is highlighted in green. To the right is a 3D reconstruction of the tumour using Mimics Software (Materialise, Leuven, Belgium) by summing the number of voxels that exceeded the intensity threshold in each plane on the T1-weighted subtraction images and multiplying by the appropriate spatial scaling factor (0.35 mm×0.35 mm×1.00 mm per voxel). (c) GFAP staining of the first cell line of CNS-1. (d) An H/E staining of infiltrating tumour cells into normal parenchyma of a Lewis rat brain (scale bar indicates 100 μm).

Similar articles

Cited by

References

    1. Ali S, Curtin JF, Zirger JM, Xiong W, King GD, Barcia C, Liu C, Puntel M, Goverdhana S, Lowenstein PR, Castro MG. Inflammatory and anti-glioma effects of an adenovirus expressing human soluble Fms-like tyrosine kinase 3 ligand (hsFlt3L): treatment with hsFlt3L inhibits intracranial glioma progression. Mol Ther. 2004;10:1071–1084. - PMC - PubMed
    1. Asai A, Miyagi Y, Sugiyama A, Gamanuma M, Hong SH, Takamoto S, Nomura K, Matsutani M, Takakura K, Kuchino Y. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J Neurooncol. 1994;19:259–268. - PubMed
    1. Auer RN, Del Maestro RF, Anderson R. A simple and reproducible experimental in vivo glioma model. Can J Neurol Sci. 1981;8:325–331. - PubMed
    1. Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J Neurooncol. 1998;36:91–102. - PubMed
    1. Benda P, Lightbody J, Sato G, Levine L, Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 1968;161:370–371. - PubMed

Publication types